Contineum Therapeutics, Inc. Class A Common Stock
Status: Publicly traded
Direct answer
Contineum Therapeutics, Inc. Class A Common Stock is publicly traded on NASDAQ under the ticker CTNM.
Contineum Therapeutics, Inc. operates as a clinical-stage biopharmaceutical enterprise, dedicated to the discovery and advancement of innovative oral small molecule therapies. Their primary focus lies in addressing neurological, inflammatory, and immunological disorders characterized by significant unmet medical needs. The company's foremost therapeutic candidate is PIPE-791, a pioneering, brain-penetrant small...
Can you invest in Contineum Therapeutics, Inc. Class A Common Stock?
Yes. Contineum Therapeutics, Inc. Class A Common Stock trades publicly on NASDAQ as CTNM.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Contineum Therapeutics, Inc. Class A Common Stock
Detailed equity research is provided by MarketSnap.